News & Perspective

Nov 11, 2008

Nov 11, 2008

Firm says 'universal' flu vaccine passed early test

(CIDRAP News) – A vaccine designed to offer protection against many strains of influenza viruses appeared safe in low doses and triggered a satisfactory immune response in a phase 1 clinical trial, the vaccine's developer announced recently.